Today: 22 June 2026
Browse Category

Stock Market 12 December 2025

SpaceX is set to join the Russell 1000 index at the end of the week, with JPMorgan analysts estimating about $4 billion in passive buying as a result. The Russell U.S. indexes are widely tracked, with $12.2 trillion benchmarked to them. Super Micro Computer shares rose in premarket trading after GF Securities upgraded the stock to Buy, citing a positive outlook following the company’s AI-server financing package. AT&T shares hovered just above their 52-week low ahead of Q2 earnings, while Pfizer’s stock slipped as CFO Dave Denton announced his departure, with Cecile Guegan stepping in as interim CFO. American Airlines shares gained in premarket trading, supported by lower jet fuel prices due to eased oil-market concerns from U.S.-Iran talks, with airlines expected to use the savings to improve margins. Sandisk and Micron Technology both saw premarket gains, with Sandisk benefiting from sector momentum after Apple’s memory-cost warning, and Micron ahead of its fiscal Q3 report, where strong AI-memory pricing is expected to drive results. China imposed export blocks on several U.S. entities, impacting Red Cat and Teal Drones, while Nokia shares declined as the company undergoes an AI-infrastructure rerating. Brent crude prices dropped sharply on renewed U.S.-Iran talks, leading to a surge in short positions. U.S. equity futures dipped despite cheaper oil, as traders focused on rates and inflation data. Marvell Technology advanced on S&P 500 inclusion and AI-networking optimism, while Keel Infrastructure rose on Russell index timing and leasing business interest. Walmart recalled Great Value Hawaiian Roll four-packs due to a contamination issue. Cognizant Technology Solutions fell over 10% after Accenture warned of weaker IT-services demand and Berenberg downgraded the stock.
Lumentum (LITE) Stock Slides on AI-Tech Selloff as Analysts Lift Price Targets to $380 — What Today’s News and Forecasts Say (Dec. 12, 2025)

Lumentum (LITE) Stock Slides on AI-Tech Selloff as Analysts Lift Price Targets to $380 — What Today’s News and Forecasts Say (Dec. 12, 2025)

Lumentum Holdings shares fell about 10% to $332 during Friday’s U.S. session, with heavy volume and wide intraday swings. The drop followed a broader selloff in AI-linked tech stocks as investors shifted away from high-valuation names. Lumentum, a key supplier of optical components for AI infrastructure, has seen over 60% of its revenue tied to AI and cloud demand, according to recent company estimates.
Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025)

Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025)

Geron Corporation shares fell 5% to $1.32 on Dec. 12 after the company announced plans to cut about one-third of its 260-person workforce. The restructuring aims to lower 2026 expenses and focus resources on RYTELO’s commercial growth. Analysts maintained a neutral stance as RYTELO’s Q3 revenue slipped 3% quarter-over-quarter to $47.2 million.
Warner Bros. Discovery Stock (WBD) Today: Netflix Deal vs. Paramount’s $30 Tender Offer, Latest News, Analyst Forecasts and What Comes Next (Dec. 12, 2025)

Warner Bros. Discovery Stock (WBD) Today: Netflix Deal vs. Paramount’s $30 Tender Offer, Latest News, Analyst Forecasts and What Comes Next (Dec. 12, 2025)

Paramount Skydance launched a $30-per-share all-cash tender offer for all of Warner Bros. Discovery on Dec. 8, 2025, challenging Netflix’s $27.75-per-share bid for WBD’s studios and HBO Max. WBD shares are trading in the high-$20s as investors weigh the rival bids, regulatory risks, and the fate of the company’s cable networks.
Freeport-McMoRan Stock (FCX) News Today, Forecasts, and Analyst Outlook (Dec. 12, 2025)

Freeport-McMoRan Stock (FCX) News Today, Forecasts, and Analyst Outlook (Dec. 12, 2025)

Freeport-McMoRan shares traded near $47.25 midday Friday, down 1.8%, as copper prices hit record highs and new class-action lawsuit notices surfaced. The stock moved between $46.82 and $48.93, with volume in the high single-digit millions. Copper reached $11,771/ton this week, with 2026 forecasts split between deficit and surplus. Investors are watching Grasberg’s recovery and U.S. policy shifts.
Royal Caribbean Cruises Ltd. (RCL) Stock Today: Buyback, Dividend, and Fed Rate Cuts Drive Momentum — Latest News, Forecasts, and Analyst Targets (Dec. 12, 2025)

Royal Caribbean Cruises Ltd. (RCL) Stock Today: Buyback, Dividend, and Fed Rate Cuts Drive Momentum — Latest News, Forecasts, and Analyst Targets (Dec. 12, 2025)

Royal Caribbean stock surged 7.4% Thursday to close at $279.70 after announcing a $2 billion share buyback and a $1.00 quarterly dividend. Shares traded near $278.74 Friday, slightly lower, with an intraday range of $276.92 to $282.57. The move follows the Federal Reserve’s rate cut, which boosted travel stocks. RCL is up about 20% year-to-date.
Broadcom Stock Slides After Q4 Earnings: AI Chip Revenue Set to Double, but Margin Pressure Rattles Investors

Broadcom Stock Slides After Q4 Earnings: AI Chip Revenue Set to Double, but Margin Pressure Rattles Investors

Broadcom reported record quarterly revenue of $18.02 billion and raised its outlook, but shares fell over 8% Friday. Investors focused on management’s warning that rising AI hardware sales will pressure gross margins, with CFO Kirsten Spears projecting a sequential decline of about 100 basis points. Fiscal year revenue hit $63.89 billion, up 24%. Free cash flow for the quarter was $7.47 billion.
Oriental Culture Holding (NASDAQ: OCG) Stock Rebounds After 89% Crash as Company Files $200M ATM Offering — Latest News, Forecasts, and Analysis (Dec. 12, 2025)

Oriental Culture Holding (NASDAQ: OCG) Stock Rebounds After 89% Crash as Company Files $200M ATM Offering — Latest News, Forecasts, and Analysis (Dec. 12, 2025)

Oriental Culture Holding (NASDAQ: OCG) shares swung from $0.65 to $1.98 on Dec. 12, 2025, after plunging 89% the previous session. The volatility followed a Dec. 11 SEC filing for a $200 million at-the-market share offering with AGP/Alliance Global Partners. Trading volume reached 59.6 million shares. The new authorization matches the company’s recent market value.
12 December 2025
Booking Holdings (BKNG) Stock News on Dec. 12, 2025: Price Action, Dividend, Buybacks, Analyst Targets, and 2026 Travel Outlook

Booking Holdings (BKNG) Stock News on Dec. 12, 2025: Price Action, Dividend, Buybacks, Analyst Targets, and 2026 Travel Outlook

Booking Holdings (BKNG) traded near $5,300 on Dec. 12, 2025, with a market cap around $172 billion, about 8% below its 52-week high. Q3 results showed $9 billion in revenue and $3.8 billion in adjusted EBITDA, both up year-over-year. The company is paying a $9.60 quarterly dividend on Dec. 31. Investors are weighing strong travel demand and shareholder returns against regulatory risks.
12 December 2025
Citigroup Stock (NYSE: C) Today: JPMorgan Upgrade Sparks Fresh Optimism for 2026 as Citi’s Turnaround Hits Key Milestones

Citigroup Stock (NYSE: C) Today: JPMorgan Upgrade Sparks Fresh Optimism for 2026 as Citi’s Turnaround Hits Key Milestones

JPMorgan upgraded Citigroup to “Overweight” on December 12, 2025, raising its price target to $124. Citi shares traded near $111.91, close to recent highs after a 59% gain this year. RBC also lifted its target to $121. Citi’s Q3 results showed $22.1 billion in revenue and $3.8 billion net income, with shares now trading around book value.
12 December 2025
Linde plc Stock (NASDAQ: LIN) News & Forecast: UBS, Evercore, Jefferies Price Targets Signal 2026 Backlog-Fueled Upside — Dec. 12, 2025

Linde plc Stock (NASDAQ: LIN) News & Forecast: UBS, Evercore, Jefferies Price Targets Signal 2026 Backlog-Fueled Upside — Dec. 12, 2025

Linde shares rose about 3% to the low-to-mid $400s after a series of analyst updates and price target changes following an investor event. Most analysts reiterated buy ratings, with targets clustering between $490 and $535. Firms cited large projects starting in 2026 and a solid earnings outlook but flagged ongoing macro uncertainty, especially in Europe. Consensus target prices remain well above current levels.
12 December 2025
AST SpaceMobile (ASTS) Stock on Dec. 12, 2025: BlueBird 6 Launch Date Shifts, Analyst Forecasts Diverge, and the Direct-to-Device Race Intensifies

AST SpaceMobile (ASTS) Stock on Dec. 12, 2025: BlueBird 6 Launch Date Shifts, Analyst Forecasts Diverge, and the Direct-to-Device Race Intensifies

AST SpaceMobile shares fell 10.6% to $75.73 on December 12 amid heavy trading, as investors reacted to news that the BlueBird 6 satellite launch had slipped from December 15 to at least December 20, according to industry trackers. The delay comes as Wall Street debates the company’s valuation and execution risks ahead of the high-profile mission.
12 December 2025
S&P Global (SPGI) Stock News Today: Price, Analyst Forecasts, and AI Partnerships Shaping the Outlook on Dec. 12, 2025

S&P Global (SPGI) Stock News Today: Price, Analyst Forecasts, and AI Partnerships Shaping the Outlook on Dec. 12, 2025

S&P Global shares traded near $502.40 midday Friday, up about 1% from Thursday’s $497.56 close. The move followed news of a multi-year Google Cloud partnership announced December 10, aimed at expanding AI and data distribution capabilities. Trading volume Thursday reached 2.6 million shares, above recent averages. Investors weighed the deal against broader market volatility tied to AI sector concerns.
12 December 2025
Bristol-Myers Squibb Stock (BMY) News, Forecasts and Analysis for Dec. 12, 2025: Dividend Hike, FDA Updates, and Wall Street’s 2026 Focus

Bristol-Myers Squibb Stock (BMY) News, Forecasts and Analysis for Dec. 12, 2025: Dividend Hike, FDA Updates, and Wall Street’s 2026 Focus

Bristol-Myers Squibb shares rose 2.5% to $52.50 by mid-day Friday after Guggenheim upgraded the stock to Buy with a $62 target. The company announced a 1.6% dividend increase to $0.63 per share, its 17th consecutive annual raise. The FDA granted Priority Review for Opdivo in Hodgkin lymphoma, and approved Breyanzi for marginal zone lymphoma earlier this month.
12 December 2025
Nike Stock (NKE) Today: Analyst Targets Split Ahead of Dec. 18 Earnings as “Win ​​Now” Turnaround Faces Margin, China, and Tariff Tests

Nike Stock (NKE) Today: Analyst Targets Split Ahead of Dec. 18 Earnings as “Win ​​Now” Turnaround Faces Margin, China, and Tariff Tests

Nike shares traded between $67.34 and $69.13 on Friday, last seen near $67.50, slightly below the previous close, as investors positioned ahead of Q2 FY2026 earnings. BTIG and Jefferies reiterated buy ratings with $100 and $115 targets, while BWG Global downgraded its view to Mixed. Volatility followed broader market pressure and debate over Nike’s turnaround and margins.
New Gold Inc (NGD) Stock on Dec. 12, 2025: 52-Week High Momentum, Coeur Buyout Terms, Analyst Forecasts, and What’s Next

New Gold Inc (NGD) Stock on Dec. 12, 2025: 52-Week High Momentum, Coeur Buyout Terms, Analyst Forecasts, and What’s Next

New Gold Inc. traded near a 52-week high at $8.32 on Dec. 12 as investors tracked Coeur Mining’s $7 billion all-stock acquisition offer. The stock’s moves now closely follow Coeur’s price due to a fixed exchange ratio of 0.4959 Coeur shares per NGD share. Analyst upgrades and gold’s rally on rate-cut expectations also supported the surge. The deal is expected to close in the first half of 2026.
Molina Healthcare Stock (NYSE: MOH) News on Dec. 12, 2025: Rally Extends as ACA Subsidy Deadline, 2026 Outlook, and Analyst Forecasts Collide

Molina Healthcare Stock (NYSE: MOH) News on Dec. 12, 2025: Rally Extends as ACA Subsidy Deadline, 2026 Outlook, and Analyst Forecasts Collide

Molina Healthcare shares traded near $169.53 on Dec. 12, 2025, following an eighth straight session of gains. The stock’s rebound comes after a steep drop earlier in the year, with shares still well below the April high of $359.97. A new diabetes care partnership in South Carolina and renewed ACA policy uncertainty have influenced recent trading.
12 December 2025
Morgan Stanley Stock (MS) Today: Shares Hover Near Record Levels as Fed Cuts Rates, Analysts Update Targets Ahead of Q4 Earnings

Morgan Stanley Stock (MS) Today: Shares Hover Near Record Levels as Fed Cuts Rates, Analysts Update Targets Ahead of Q4 Earnings

Morgan Stanley stock traded at $180.51 as of 15:48 UTC Friday, near a record high set the previous session. Shares have surged from a 52-week low of $94.33 in April, boosted by a Federal Reserve rate cut and renewed dealmaking activity. The Fed’s decision on Dec. 10 was split, with three officials dissenting. Wall Street analysts note the stock now trades above many 12-month target prices.

Stock Market Today

  • Staying Invested Outperforms Market Timing, History Shows
    June 22, 2026, 8:37 AM EDT. As the S&P 500, Nasdaq, and Dow approach record highs, investors face uncertainty about market valuation and timing. Historical data reveals the average bear market declines about 27%, rising to 35% if coinciding with a recession. However, avoiding the market during downturn fears has proved costlier; for example, since a Deutsche Bank recession warning in June 2023, the S&P 500 surged 76%. Similarly, since the April 2025 low, returns near 53% demonstrate the risks of exiting prematurely. Warren Buffett warns investors who buy only during comfort and sell amid fear often lose money despite long-term gains. The key takeaway: staying invested in strong growth stocks over time often outperforms attempts to time the market.

Latest articles

Jersey Mike’s edges ahead of Chick-fil-A in ACSI fast-food survey

Jersey Mike’s edges ahead of Chick-fil-A in ACSI fast-food survey

22 June 2026
Jersey Mike’s surged to No. 1 in the 2026 American Customer Satisfaction Index quick-service ranking with a score of 84, ending Chick-fil-A’s 11-year streak as top brand, as ACSI cited Jersey Mike’s freshness, value, rapid growth, and digital pickup amid industry pressure from lagging sales growth and rising menu prices.
AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

22 June 2026
AbbVie will acquire Apogee Therapeutics for $10.9 billion in cash, paying a 49.49% premium for access to Apogee’s experimental eczema drug zumilokibart; Apogee shares surged 48% pre-market, while AbbVie rose 1.3%, as the deal—pending approvals—bets on Phase 3 success to extend AbbVie’s immunology leadership amid falling Humira sales.
Getty Images (NYSE:GETY) soars premarket after OpenAI deal brings licensing story back

Getty Images (NYSE:GETY) soars premarket after OpenAI deal brings licensing story back

22 June 2026
Getty Images (NYSE:GETY) soared 167.7% to $1.62 in premarket trading after announcing a multi-year deal to display licensed images in OpenAI’s ChatGPT, but financial terms were not disclosed, leaving investors to price the stock’s surge without clarity on revenue impact as the company remains under NYSE minimum-price compliance pressure.
Go toTop